Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Retrovirology

Showing results (991-1000 of 1,647) with videos related to

Pageof 165
Sort By:
Retrovirology|March 19, 2013
The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individualsHangxing Yu, Shariq M Usmani, Alexandra Borch, et al.
Retrovirology|March 22, 2013
Molecular signatures of T-cell inhibition in HIV-1 infectionMarie Larsson, Esaki M Shankar, Karlhans F Che, et al.
Retrovirology|March 22, 2013
The transmembrane domain of HIV-1 Vpu is sufficient to confer anti-tetherin activity to SIVcpz and SIVgor Vpu proteins: cytoplasmic determinants of Vpu functionSilvia F Kluge, Daniel Sauter, Michael Vogl, et al.
Retrovirology|April 6, 2013
HIV restriction in quiescent CD4⁺ T cellsJerome A Zack, Sohn G Kim, Dimitrios N Vatakis
Retrovirology|May 9, 2013
Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesisMineki Saito, Reiko Tanaka, Shiho Arishima, et al.
Retrovirology|May 3, 2013
Platelet activation suppresses HIV-1 infection of T cellsTheodros Solomon Tsegaye, Kerstin Gnirß, Niels Rahe-Meyer, et al.
Retrovirology|May 4, 2013
Within-host and between-host evolutionary rates across the HIV-1 genomeSamuel Alizon, Christophe Fraser
Retrovirology|December 19, 2012
High-resolution deep sequencing reveals biodiversity, population structure, and persistence of HIV-1 quasispecies within host ecosystemsLi Yin, Li Liu, Yijun Sun, et al.
Retrovirology|December 22, 2012
APOBEC3G and APOBEC3F rarely co-mutate the same HIV genomeDiako Ebrahimi, Firoz Anwar, Miles P Davenport
Retrovirology|December 22, 2012
WIP1 deficiency inhibits HTLV-1 Tax oncogenesis: novel therapeutic prospects for treatment of ATL?Nicolas Gillet, Alexandre Carpentier, Pierre-Yves Barez, et al.
Pageof 165

Showing results (991-1000 of 1,647) with videos related to

Sort By:
Pageof 165
Retrovirology|March 19, 2013
The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individualsHangxing Yu, Shariq M Usmani, Alexandra Borch, et al.
Retrovirology|March 22, 2013
Molecular signatures of T-cell inhibition in HIV-1 infectionMarie Larsson, Esaki M Shankar, Karlhans F Che, et al.
Retrovirology|March 22, 2013
The transmembrane domain of HIV-1 Vpu is sufficient to confer anti-tetherin activity to SIVcpz and SIVgor Vpu proteins: cytoplasmic determinants of Vpu functionSilvia F Kluge, Daniel Sauter, Michael Vogl, et al.
Retrovirology|April 6, 2013
HIV restriction in quiescent CD4⁺ T cellsJerome A Zack, Sohn G Kim, Dimitrios N Vatakis
Retrovirology|May 9, 2013
Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesisMineki Saito, Reiko Tanaka, Shiho Arishima, et al.
Retrovirology|May 3, 2013
Platelet activation suppresses HIV-1 infection of T cellsTheodros Solomon Tsegaye, Kerstin Gnirß, Niels Rahe-Meyer, et al.
Retrovirology|May 4, 2013
Within-host and between-host evolutionary rates across the HIV-1 genomeSamuel Alizon, Christophe Fraser
Retrovirology|December 19, 2012
High-resolution deep sequencing reveals biodiversity, population structure, and persistence of HIV-1 quasispecies within host ecosystemsLi Yin, Li Liu, Yijun Sun, et al.
Retrovirology|December 22, 2012
APOBEC3G and APOBEC3F rarely co-mutate the same HIV genomeDiako Ebrahimi, Firoz Anwar, Miles P Davenport
Retrovirology|December 22, 2012
WIP1 deficiency inhibits HTLV-1 Tax oncogenesis: novel therapeutic prospects for treatment of ATL?Nicolas Gillet, Alexandre Carpentier, Pierre-Yves Barez, et al.
Pageof 165